SQ-LIP-000007 · v1.2 (archived) · View current version →
Is lipedema associated with thyroid disease?
Based on currently indexed evidence, lipedema appears to be associated with elevated rates of thyroid disease, particularly hypothyroidism and chronic autoimmune thyroiditis. Multiple cross-sectional cohorts and surveys consistently report higher thyroid disorder prevalence in lipedema patients compared to general population estimates or lymphedema controls: a German survey (n=209) found hypothyroidism in 35.9% of lipedema patients; a large Spanish cohort (n=1803) identified thyroid disorders as a common comorbidity; an Italian cohort (n=360) reported elevated rates of chronic autoimmune thyroiditis specifically; and a comparative cohort found thyroid disease in 24.4% of lipedema vs 14.9% of lymphedema patients. Cross-national data further show variable but consistently notable hypothyroidism rates: 31.6% in a Polish cohort, 19.4% in a Brazilian cohort, and 11.7% in a Dutch cohort. All supporting studies are observational (cross-sectional or retrospective cohort) and rated low-to-moderate quality, with no randomized or prospective controlled designs. No study has adequately adjusted for confounders such as BMI, sex, healthcare-seeking behavior, or background population thyroid disease prevalence, and none establishes causality or direction of association. The evidence is consistent in direction across multiple populations but remains preliminary.
Knowledge freshness = share of the 6 indexed evidence sources from the last 5 years (newest 2025, oldest 2019) . Low freshness flags an ageing evidence base — not that the answer is wrong.
Evidence over time
supporting contradicting refining / context Each dot is a study, placed by year and coloured by whether the linked claim supports or contradicts the answer. As the surveillance loop runs, claim revisions and new evidence will extend this timeline.
Choose a format (Vancouver default). Citing a version captures the evidence state on that date; this page shows the current version — see version history.
What changed in this version
This update added cross-national comparative data from Brazilian, Polish, and Dutch cohorts showing variable but consistently notable hypothyroidism prevalence rates in lipedema patients (19.4%, 31.6%, and 11.7%, respectively), reinforcing the cross-population consistency of the association while highlighting inter-cohort variability.
Supporting claims
- SCR-LIP-000020 supporting
Thyroid disorders may be more frequent in lipedema than in lymphedema, with a cross-sectional cohort reporting thyroid disease in 24.4% of lipedema vs 14.89% of lymphedema patients.
Lipedema and Hypermobility Spectrum Disorders Sharing Pathophysiology: A Cross-Sectional Observational Study — Fiengo & Sbarbati (2025) - SCR-LIP-000134 supporting
In a survey of 209 German women with lipedema who underwent liposuction, hypothyroidism was present in 35.9% of participants, a frequency described as far beyond the average prevalence in the general German population.
New Insights on Lipedema: The Enigmatic Disease of the Peripheral Fat — Bauer et al. (2019) · Disease progression and comorbidities in lipedema patients: A 10‐year retrospective analysis — Ghods et al. (2020) - SCR-LIP-000135 supporting
In a cohort of 1803 lipedema patients in Spain, thyroid disorders were reported as a common comorbidity alongside other inflammatory and connective tissue conditions.
Clinical Signs at Diagnosis and Comorbidities in a Large Cohort of Patients with Lipedema in Spain — Simarro Blasco et al. (2025) - SCR-LIP-000136 supporting
In a cohort of 360 Italian women with lipedema, the prevalence of chronic autoimmune thyroiditis was higher compared to the general population.
Observational Study on a Large Italian Population with Lipedema: Biochemical and Hormonal Profile, Anatomical and Clinical Evaluation, Self-Reported History — Patton et al. (2024)
Contradictory claims
- None indexed yet.
Refining / context
- SCR-LIP-000137 context
In a Brazilian cross-sectional survey, hypothyroidism was reported in 19.4% of women with lipedema, compared to 31.6% in a Polish cohort and 11.7% in a Dutch cohort, indicating variable but notable rates of thyroid disease comorbidity across populations.
Lipedema prevalence and risk factors in Brazil — Amato et al. (2022)
Major uncertainty
No study has established causality, direction of association, or adequately controlled for confounders (BMI, sex, healthcare-seeking bias, background population thyroid prevalence). The variability in hypothyroidism rates across populations (11.7%–35.9%) may reflect differences in background prevalence, diagnostic criteria, or ascertainment bias rather than a true differential lipedema-specific risk. All evidence is low-to-moderate quality observational data; no prospective controlled studies or studies with matched controls exist.
Version history
- SQ-LIP-000007 · v1.2 — 2026-05-31 — This update added cross-national comparative data from Brazilian, Polish, and Dutch cohorts showing variable but consistently notable hypothyroidism prevalence rates in lipedema patients (19.4%, 31.6%, and 11.7%, respectively), reinforcing the cross-population consistency of the association while highlighting inter-cohort variability. · view this version
- SQ-LIP-000007 · v1.1 — 2026-05-31 — This update substantially strengthened the evidence base by adding three new cohorts (n=209 German, n=1803 Spanish, n=360 Italian) that consistently report elevated thyroid disorder prevalence—including specifically chronic autoimmune thyroiditis—in lipedema patients, upgrading two claims to moderate quality and broadening the finding beyond a single comparison cohort. · view this version
- SQ-LIP-000007 · v1.0 — 2026-05-30 — founding index (5 claims) · view this version
Key references
DOI:10.3390/jcm14207195 · DOI:10.1097/prs.0000000000006280 · DOI:10.1111/dth.14534 · DOI:10.3390/biomedicines13123049 · DOI:10.3390/ijms25031599 · DOI:10.1590/1677-5449.202101982